Paperpal Prime Logo

International Journal of Oncology : Impact Factor & More

eISSN: 1791-2423pISSN: 1019-6439

Aims and Scope of International Journal of Oncology

The International Journal of Oncology is a monthly peer-reviewed medical journal of oncology, published by Spandidos Publications. It was established in 1992 and the editor-in-chief is Demetrios A. Spandidos (University of Crete). According to the Journal Citation Reports, the journal has a 2021 impact factor of 5.65. Less

Key Metrics

CiteScore
11.1
Eigenfactor
0.01 - 0.05
Impact Factor
5 - 10
SJR
Q1Oncology
SNIP
1.13
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on International Journal of Oncology

International Journal of Oncology Journal Specifications

Overview
Publisher SPANDIDOS PUBL LTD
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1992
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in International Journal of Oncology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in International Journal of Oncology

The neural stem cell‑NSCLC axis: Molecular drivers, microenvironment crosstalk and emerging therapies (Review).
  • 1 Sep 2026
  • International journal of oncology
Retracted] Glycyrrhetinic acid induces G1‑phase cell cycle arrest in human non‑small cell lung cancer cells through endoplasmic reticulum stress pathway.
  • 1 Sep 2026
  • International journal of oncology
New insights into the physiological, pathological and pharmacological roles of voltage‑gated potassium channel Kv10.1 in cancer (Review).
  • 1 Sep 2026
  • International journal of oncology
T‑box transcription factor 15 regulated by methyltransferase‑like 3‑mediated N6‑methyladenosine modification promotes immune escape and progression of gastric cancer by activating matrix metalloproteinase 14 transcription.
  • 1 Sep 2026
  • International journal of oncology
Retracted] Phenotypic characterization of human prostatic stromal cells in primary cultures derived from human tissue samples.
  • 1 Sep 2026
  • International journal of oncology
Glycolysis‑driven immunosuppression in gastric cancer: Metabolic crosstalk between tumor cells and the immune microenvironment (Review).
  • 1 Sep 2026
  • International journal of oncology
The neural stem cell‑NSCLC axis: Molecular drivers, microenvironment crosstalk and emerging therapies (Review).
  • 1 Sep 2026
  • International journal of oncology
Retracted] Glycyrrhetinic acid induces G1‑phase cell cycle arrest in human non‑small cell lung cancer cells through endoplasmic reticulum stress pathway.
  • 1 Sep 2026
  • International journal of oncology
New insights into the physiological, pathological and pharmacological roles of voltage‑gated potassium channel Kv10.1 in cancer (Review).
  • 1 Sep 2026
  • International journal of oncology
T‑box transcription factor 15 regulated by methyltransferase‑like 3‑mediated N6‑methyladenosine modification promotes immune escape and progression of gastric cancer by activating matrix metalloproteinase 14 transcription.
  • 1 Sep 2026
  • International journal of oncology
Retracted] Phenotypic characterization of human prostatic stromal cells in primary cultures derived from human tissue samples.
  • 1 Sep 2026
  • International journal of oncology
Glycolysis‑driven immunosuppression in gastric cancer: Metabolic crosstalk between tumor cells and the immune microenvironment (Review).
  • 1 Sep 2026
  • International journal of oncology

FAQs on International Journal of Oncology